(Q38577325)

4 September 2017

Advances in the care of patients with mucinous colorectal cancer (English)

1 reference

4 September 2017

1 reference

Niek Hugen

1

1 reference

4 September 2017

Gina Brown

2

1 reference

4 September 2017

Robert Glynne-Jones

3

1 reference

4 September 2017

Johannes H W de Wilt

4

1 reference

4 September 2017

Iris D Nagtegaal

5

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 September 2015

1 reference

Nature Reviews Clinical Oncology

4 September 2017

1 reference

4 September 2017

13

1 reference

4 September 2017

6

1 reference

4 September 2017

361-369

1 reference

4 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Insight into mucinous colorectal carcinoma: clues from etiology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Signet ring cell differentiation in mucinous colorectal carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Is mucinous carcinoma of the colorectum a distinct genetic entity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

The molecular background of mucinous carcinoma beyond MUC2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Reduced rate of copy number aberrations in mucinous colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Clinicopathological Significance of Mucin 2 Immuno-histochemical Expression in Colorectal Cancer: A Meta-Analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucins in cancer: function, prognosis and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Overall survival is improved in mucinous adenocarcinoma of the colon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

What is the role for the circumferential margin in the modern treatment of rectal cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Low rectal cancer: a call for a change of approach in abdominoperineal resection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Moyamoya disease and moyamoya syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Prognostic implication of mucinous histology in resected colorectal cancer liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Metastatic pattern in colorectal cancer is strongly influenced by histological subtype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Clinicopathological characteristics of mucinous carcinoma of the colon and rectum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Clinical significance of signet ring cell rectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Significance of signet-ring cells in patients with colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Combining two strategies to improve perfusion and drug delivery in solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Adjuvant chemotherapy improves overall survival after TME surgery in mucinous carcinoma of the rectum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Effects of radiotherapy on different histopathological types of rectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous Rectal Adenocarcinoma Can Be Associated to Tumor Downstaging after Preoperative Chemoradiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

A novel risk-adjusted nomogram for rectal cancer surgery outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

The TME Trial After a Median Follow-up of 6 Years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Improved overall survival for patients with rectal cancer since 1990: The effects of TME surgery and pre-operative radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous versus nonmucinous rectal carcinomas: differentiation with MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Drug delivery: Stealth particles give mucus the slip

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.140

Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?

31 March 2020

1 reference

12 December 2020

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.

1 reference

12 December 2020

Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.

1 reference

12 December 2020

BRAFMutation in Metastatic Colorectal Cancer

1 reference

12 December 2020

10.1038/NRCLINONC.2015.140

Identifiers

DOI

1 reference

4 September 2017

1 reference